Crispr Therapeutics Correlations

CRSP Stock

USD 42.62 1.40 3.40%

The current 90-days correlation between Crispr Therapeutics and Beam Therapeutics is 0.74 (i.e., Poor diversification). The correlation of Crispr Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Crispr Therapeutics Correlation With Market

Modest diversification

The correlation between Crispr Therapeutics AG and DJI is 0.26 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Crispr Therapeutics AG and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Crispr Therapeutics AG. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

Moving together with Crispr Stock

0.65	CSCO	Cisco Systems	Pair Corr
0.67	INTC	Intel Sell-off Trend	Pair Corr
0.75	DD	Dupont De Nemours	Pair Corr

Moving against Crispr Stock

0.32	SCLX	Scilex Holding	Pair Corr
0.32	ASMB	Assembly Biosciences Earnings Call Tomorrow	Pair Corr
0.58	MRK	Merck Company	Pair Corr

Related Correlations Analysis

	BEAM	EDIT	CRBU	VERV	NTLA	FATE	REGN	NVO	SRPT	CWBR
BEAM		0.55	0.2	0.47	0.53	0.41	0.24	0.25	0.22	0.0	BEAM
EDIT	0.55		-0.25	0.18	0.18	-0.06	0.05	0.15	-0.21	0.0	EDIT
CRBU	0.2	-0.25		-0.13	0.79	0.93	0.55	0.53	0.86	0.0	CRBU
VERV	0.47	0.18	-0.13		-0.08	-0.01	-0.26	-0.24	0.06	0.0	VERV
NTLA	0.53	0.18	0.79	-0.08		0.9	0.61	0.6	0.62	0.0	NTLA
FATE	0.41	-0.06	0.93	-0.01	0.9		0.54	0.54	0.78	0.0	FATE
REGN	0.24	0.05	0.55	-0.26	0.61	0.54		0.52	0.56	0.0	REGN
NVO	0.25	0.15	0.53	-0.24	0.6	0.54	0.52		0.46	0.0	NVO
SRPT	0.22	-0.21	0.86	0.06	0.62	0.78	0.56	0.46		0.0	SRPT
CWBR	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		CWBR
	BEAM	EDIT	CRBU	VERV	NTLA	FATE	REGN	NVO	SRPT	CWBR

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

FATE	+ 0.93	CRBU
FATE	+ 0.9	NTLA
SRPT	+ 0.86	CRBU
NTLA	+ 0.79	CRBU
SRPT	+ 0.78	FATE
SRPT	+ 0.62	NTLA

High negative correlations

REGN	- 0.26	VERV
CRBU	- 0.25	EDIT
NVO	- 0.24	VERV
SRPT	- 0.21	EDIT
VERV	- 0.13	CRBU
NTLA	- 0.08	VERV

Risk-Adjusted Indicators

There is a big difference between Crispr Stock performing well and Crispr Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Crispr Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
BEAM	3.43	(0.14)	0.00	(0.14)	0.00	0.00	7.58	(8.18)	23.04
EDIT	6.61	0.70	0.07	0.16	7.93	(8.37)	12.20	(9.30)	119.53
CRBU	3.01	(0.84)	0.00	(0.83)	0.00	0.00	5.26	(7.09)	17.85
VERV	4.51	0.32	0.06	0.13	4.90	(4.90)	11.11	(8.25)	30.05
NTLA	3.71	(0.38)	0.00	(0.27)	0.00	0.00	7.76	(7.56)	20.66
FATE	4.59	(0.90)	0.00	(0.46)	0.00	0.00	8.48	(9.56)	22.21
REGN	1.59	(0.12)	0.00	(0.38)	0.00	0.00	2.82	(3.61)	9.27
NVO	2.31	(0.47)	0.00	(1.02)	0.00	0.00	4.36	(4.25)	17.90
SRPT	2.30	(0.63)	0.00	(0.50)	0.00	0.00	4.28	(5.18)	32.12
CWBR	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Crispr Therapeutics Corporate Management

Samarth Kulkarni	Chief Business Officer	Profile
James JD	General Secretary	Profile
Susan Kim	Vice Relations	Profile
Craig Mello	Scientific Member	Profile
Lawrence Klein	Chief Officer	Profile
Chad Cowan	Scientific Founder	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC